Emergent Executive and Leadership Team

Karen Olsen, the Senior Chief Marketing Officer & Specialist at Emergent, directs all global brand positioning and product commercialization strategies for the company's extensive portfolio of public health countermeasures. Overseeing market penetration for NARCAN Nasal Spray and various vaccine lines, the Senior Chief Marketing Officer & Specialist ensures that life-saving medical solutions reach critical government and commercial channels across North American markets. This leadership role involves analyzing complex epidemiological data to forecast demand for anthrax and smallpox treatments while aligning promotional activities with evolving public health mandates. By optimizing the outreach funnel for specialized medical products, Karen Olsen directly impacts the company's ability to address accidental and deliberate health threats. Ultimately, the Senior Chief Marketing Officer & Specialist secures long-term market relevance by translating intricate scientific value propositions into actionable intelligence for healthcare providers and emergency response agencies worldwide.

Michelle Pepin, the Chief Human Resources Officer at Emergent, architects the organizational culture and talent acquisition frameworks necessary to support high-stakes life sciences manufacturing. Overseeing the recruitment of specialized scientific and technical personnel, the Chief Human Resources Officer ensures that the workforce maintains the rigorous compliance standards required for producing vaccines and chemical warfare decontamination kits. This leadership role involves designing performance management systems that incentivize innovation in drug development while fostering a safe, high-performance environment across all manufacturing facilities. By aligning human capital strategies with the company's mission to counter public health threats, Michelle Pepin directly impacts operational efficiency and employee retention. Ultimately, the Chief Human Resources Officer drives the internal organizational health required to sustain complex technology transfers and analytical development services, ensuring that the company possesses the human expertise to meet global health security demands.

Howard Anderson, the Senior Vice President & Chief Information Officer at Emergent, directs the digital transformation and cybersecurity infrastructure essential for protecting sensitive pharmaceutical research and manufacturing data. Overseeing the integration of advanced analytics into the drug development lifecycle, the Senior Vice President & Chief Information Officer ensures that internal systems support the rapid scaling of contract development and manufacturing services. This leadership role involves managing the technological backbone for global supply chain visibility and regulatory compliance reporting across all operational regions. By implementing robust data protection protocols for proprietary vaccine research, Howard Anderson directly impacts the integrity and security of the company's intellectual property. Ultimately, the Senior Vice President & Chief Information Officer optimizes the digital ecosystem to facilitate seamless collaboration between research teams and manufacturing units, ensuring that technological capabilities remain aligned with the company's critical public health objectives.

Stephanie Duatschek, the Executive VP & Chief Growth Officer at Emergent, architects the strategic expansion of the company's business development pipeline and partnership networks. Overseeing the identification of new market opportunities for emerging therapeutics like Lassa fever and Marburg virus preventatives, the Executive VP & Chief Growth Officer ensures that the company maintains a competitive edge in the global biodefense sector. This leadership role involves negotiating high-value contracts for manufacturing services and identifying potential acquisitions that complement existing product lines such as anthrax and smallpox treatments. By driving long-term revenue growth through diversified portfolio management, Stephanie Duatschek directly impacts the company's financial stability and market reach. Ultimately, the Executive VP & Chief Growth Officer secures the future of the organization by aligning strategic investments with the evolving landscape of naturally occurring and deliberate public health threats.